Lupin
Mumbai, Maharashtra, India · Biotechnology, Health Care, Medical
Lupin is a Mumbai-based pharma major dedicated to advancing medical science and improving patient lives globally.
Key facts
- Headquarters
- Mumbai, Maharashtra, India
- Employees
- 46
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- lupin.com
- Company page
Recent activity at Lupin
- : Lupin Ltd Appoints Brian Savage as President and Chief Legal Officer
- : Lupin and Tenpoint Therapeutics Partner to Commercialize Yuvezzi in European Markets.
- : Lupin Partners with LABORATORIOS ERN for Luforbec Launch in Spain to Enhance Respiratory Therapy Access.
- : Lupin and Mylan Partner to Commercialize Enbrel® Biosimilar
- : Lupin completes acquisition of VISUfarma
- : Lupin Limited Appoints Thierry Volle as President of EMEA
- : Lupin Announces Strategic Partnership Program to Enhance Reach of PrecisionSphere™ Long-Acting Injectable Platform.
- : Lupin acquires UK-based Renascience Pharma
- : Lupin acquires Renascience Pharma for GBP 12.3 mn
- : Lupin acquires Renascience Pharma for GBP 12.3 mn
Leadership
- Pradumn Mishra, Senior Director
- Brian Savage, President
- Thierry Volle, President
- Andrew McDonald, Director of Finance
- Amit Agarwal, Director
- Abdelaziz Toumi, Chief Executive Officer
- Ranjana Pathak, Chief Quality Officer
- Christoph Funke, Chief Technical Operations Officer
- Rakesh Bhardwaj, Chief Information Officer
Verified email and direct lines for Lupin’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Lupin in the news
- Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States - Lupin (Aug 10, 2026)
- Lupin Announces Approval from U.S. FDA for Pitolisant Tablets - Lupin | Press Release - Lupin (Aug 17, 2026)
- Lupin Announces New U.S. Manufacturing Facility and $250 Million Domestic Investment - Association for Accessible Medicines (Oct 09, 2025)
- Lupin and Tenpoint Therapeutics Announce Strategic Partnership to Commercialize YUVEZZI™ in the European Union, the United Kingdom, Switzerland, Norway, and Iceland - Lupin | Press Release - Lupin (Aug 20, 2026)
- Lupin Receives U.S. FDA Approval for Famotidine Injection, USP - PR Newswire (May 13, 2026)
- Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection - Lupin | Press Release - Lupin (Jul 31, 2026)
- Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy - PR Newswire (Jul 21, 2026)
- Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets - Lupin | Press Release - Lupin (Jun 26, 2026)
Companies similar to Lupin
- Leapcure · Biotechnology, Health Care, Medical, Pharmaceutical
- Specialised Therapeutics · Biotechnology, Health Care, Medical, Pharmaceutical
- N-Power Medicine · Biotechnology, Health Care, Medical, Pharmaceutical
- Ellipses Pharma Limited · Biotechnology, Health Care, Medical, Pharmaceutical
- Shuttle Pharmaceutical Holdings · Biotechnology, Health Care, Medical, Pharmaceutical
About Lupin: questions and answers
What does Lupin do?
Lupin is a Mumbai-based pharma major dedicated to advancing medical science and improving patient lives globally.
Where is Lupin headquartered?
Lupin is headquartered in Mumbai, Maharashtra, India.
How many employees does Lupin have?
Lupin has about 46 employees.
Who leads Lupin?
Brian Savage is a President at Lupin.
What is the latest news on Lupin?
On Oct 22, 2026, Lupin Ltd Appoints Brian Savage as President and Chief Legal Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy